Key clinical point: Nearly half of patients with COVID-19 shed viral RNA in feces, suggesting that stool testing and prevention of fecal-oral transmission may be needed to combat the ongoing pandemic.
Major finding: Approximately 41% of patients shed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in feces.
Study details: A systematic review and meta-analysis involving 23 published and 6 preprint studies.
Disclosures: Dr. Sharma disclosed relationships with Medtronic, Fujifilm, Boston Scientific, and others. Dr. Johnson disclosed no relevant conflicts of interest.
Parasa S et al. JAMA Network Open. 2020 Jun 11. doi: 10.1001/jamanetworkopen.2020.11335.